A review: Fentanyl and non-pharmaceutical fentanyls

• Published in: Drug and alcohol dependence Vol. 171; pp. 107 - 116
• Main Authors: Suzuki, Joji, El-Haddad, Saria
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 01.02.2017; Elsevier Science Ltd
• Subjects: Analgesics, Opioid - administration & dosage; Analgesics, Opioid - adverse effects; Citations; Documents; Drug overdose; Drug Overdose - diagnosis; Drug Overdose - epidemiology; Drug Overdose - prevention & control; Fatalities; Fentanyl; Fentanyl - administration & dosage; Fentanyl - adverse effects; Grey literature; Health care management; Health education; Health risks; Heroin; Heroin - administration & dosage; Heroin - adverse effects; Humans; Non-pharmaceutical fentanyl; Opioid use disorder; Opioid-Related Disorders - diagnosis; Opioid-Related Disorders - epidemiology; Opioid-Related Disorders - prevention & control; Opioids; Outbreaks; Overdose; Overdoses; Patients; Pharmaceuticals; Pharmacology; Psychiatry; Public health; Scientific papers; Search engines; United States - epidemiology; United States > US; Fentanyl; Overdose; Non-pharmaceutical fentanyl; Opioid use disorder; opioid use disorder; overdose; non-pharmaceutical fentanyl

•Fentanyl and non-pharmaceutical fentanyls (NPF) are contributing to overdoses.•Overdoses may be more likely from fentanyl products due to their extreme potency.•Clinicians, patients and families should be educated about the dangers of fentanyl. Fentanyl and non-pharmaceutical fentanyls (NPFs) have...